ADVERTISEMENT
In March 2024, an amazing breakthrough emerged that could change the way we treat cancer.
Used to treat a fatal form of brain cancer also known as glioblastoma, the therapy trial saw ‘dramatic responses within days’ for the patients in the trial.
Researchers and surgeons out of the Mass General Brigham healthcare system use a new approach to CAR-T therapy, a complex and personalized treatment that prompts your immune system to attack the cancer cells.
Usually used to treat leukaemia, CAR-T therapy harnesses the patient’s own immune system to treat their condition. Typically, a patient’s blood is taken and sent to a lab where it’s ‘trained’ to fight the cancer cells before being transferred back to the patient and administered to treat their condition.
